CANU, LETIZIA
 Distribuzione geografica
Continente #
NA - Nord America 3.546
EU - Europa 2.504
AS - Asia 842
OC - Oceania 32
SA - Sud America 22
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.959
Nazione #
US - Stati Uniti d'America 3.536
RU - Federazione Russa 959
PL - Polonia 572
IT - Italia 347
IE - Irlanda 241
SG - Singapore 236
HK - Hong Kong 229
SE - Svezia 158
CN - Cina 148
IN - India 65
JO - Giordania 50
FI - Finlandia 43
ID - Indonesia 39
CH - Svizzera 35
DE - Germania 34
GB - Regno Unito 34
AU - Australia 32
VN - Vietnam 23
LU - Lussemburgo 20
BR - Brasile 19
KR - Corea 17
JP - Giappone 15
BE - Belgio 14
ES - Italia 12
CA - Canada 9
CI - Costa d'Avorio 9
NL - Olanda 9
TR - Turchia 6
UA - Ucraina 6
AT - Austria 3
IQ - Iraq 3
LT - Lituania 3
EC - Ecuador 2
FR - Francia 2
IR - Iran 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
BG - Bulgaria 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MA - Marocco 1
MD - Moldavia 1
MU - Mauritius 1
NP - Nepal 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 6.959
Città #
Santa Clara 1.102
Warsaw 566
Fairfield 377
Dublin 241
Ashburn 230
Singapore 198
Woodbridge 184
Hong Kong 175
Chandler 168
Seattle 148
Houston 140
Cambridge 139
Wilmington 112
Ann Arbor 102
Moscow 80
Altamura 79
Lawrence 78
Florence 68
Princeton 60
Beijing 59
Mumbai 49
Boston 40
Jakarta 39
Bern 32
Milan 32
Melbourne 30
Shanghai 28
Helsinki 21
Dong Ket 20
New York 18
San Diego 18
Boardman 17
Seoul 17
Buffalo 16
Kent 16
West Jordan 16
Dudelange 15
Scuola 15
Brussels 14
Medford 14
Falls Church 13
Rome 11
Barcelona 10
Abidjan 9
Gumyojicho 9
Los Angeles 9
Prato 9
Redmond 9
Bremen 8
Toronto 8
Yubileyny 8
Jacksonville 7
Lappeenranta 7
Norwalk 7
Parabiago 7
Pune 7
Cagliari 6
Chennai 6
Fukuoka 6
Guangzhou 6
Parma 6
Redwood City 6
Chiswick 5
Fontebuona 5
Hillsboro 5
London 5
Luxembourg 5
Nanjing 4
Phoenix 4
São Paulo 4
Trieste 4
Vaiano 4
Andover 3
Baghdad 3
Genoa 3
Naples 3
Rui'an 3
Xi'an 3
A Coruña 2
Barletta 2
Belo Horizonte 2
Bologna 2
Brescia 2
Colombo 2
Council Bluffs 2
Frankfurt am Main 2
Fucecchio 2
Hanover 2
Istanbul 2
Izmir 2
Melito Di Napoli 2
Nadarzyn 2
Old Bridge 2
Padova 2
Pisa 2
Prescot 2
Radomsko 2
Reston 2
Romola 2
Schweinfurt 2
Totale 5.054
Nome #
2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma 270
Metformin as a new anti-cancer drug in adrenocortical carcinoma 259
NEW INSIGHTS IN THE CLINICAL AND TRANSLATIONAL RELEVANCE OF miR483-5p IN ADRENOCORTICAL CANCER 239
DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: Beyond pheochromocytomas and paragangliomas 238
15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma 153
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 149
Fascin-1 is a Novel Prognostic Biomarker Associated with Tumor Invasiveness in Adrenocortical Carcinoma. 147
Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis. 137
DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA: A MONOCENTRIC PRELIMINARY STUDY. 135
Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE). 129
Mitochondrial function and content in Pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers 125
The microenvironment induces collective migration in SDHB-silenced mouse pheochromocytoma spheroids 122
Morphofunctional effects of mitotane on mitochondria in human adrenocortical cancer cells. 122
The role of PPAR-γ system in normal and tumoral corticotroph pituitary and adrenal cells. 121
Ipertensione ed esercizio fisico 121
Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas. 120
Analysis of circulating extracellular vesicle-associated microRNAs in cortisol-producing adrenocortical tumors 116
Caratterizzazione genomica del carcinoma surrenalico 116
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. 114
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/ mTOR axis in metastatic pheochromocytoma/ paraganglioma 112
SDHx and Non-Chromaffin Tumors: A Mediastinal Germ Cell Tumor Occurring in a Young Man with Germline SDHB Mutation 111
Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study 109
Impact of 123I-MIBG Scintigraphy on Clinical Decision-Making in Pheochromocytoma and Paraganglioma 103
Novel Somatic Mutations in the Catalytic Subunit of the Protein Kinase A as a Cause of Adrenal Cushing's Syndrome: A European Multicentric Study. 102
Prognostic and monitoring value of circulating tumour cells in adrenocortical carcinoma: a preliminary monocentric study. 101
Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma 99
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 99
Pitfalls in Genetic Analysis of Pheochromocytomas/Paragangliomas-Case Report. 97
Feocromocitoma/Paraganglioma: aspetti radiologici ed associazione con seconde neoplasie. 96
Stimulated expression of CXCL12 in adrenocortical carcinoma by the ppargamma ligand rosiglitazone impairs cancer progression 95
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: A multicenter interobserver variation analysis using virtual microscopy: A Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) 94
Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function 92
Sunitinib in the therapy of malignant paragangliomas: Report on the efficacy in a sdhb mutation carrier and review of the literature 92
Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-PronO study): A European network for the study of adrenal tumors retrospective study 90
Metodiche di dosaggio di metanefrine e catecolamine: rischi e variabili interpretative per i dosaggi effettuati in centri non specializzati 88
Case Report: Adrenocortical Oncocytoma in a Patient with a Previous Contralateral Adrenalectomy for a Cortisol-Secreting Adenoma 87
Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study 87
Adrenocortical carcinoma: Current treatment options 82
ENSAT Registry-Based Randomized Clinical Trials for Adrenocortical Carcinoma 81
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy 81
Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia 81
Management and outcome of metastatic pheochromocytomas/paragangliomas: an overview 80
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy 79
Outcome and genetic analysis of patients affected by retinal capillary hemangioblastoma in von hippel lindau syndrome 79
Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC 78
Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer 78
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 77
Tumour microenvironment in pheochromocytoma and paraganglioma 75
The 3D in vitro Adrenoid cell model recapitulates the complexity of the adrenal gland 74
Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience 74
Urine steroid metabolomics as a novel tool for detection of recurrent adrenocortical carcinoma 73
[Arterial hypertension and RU-486: a complex case of secondary hypertension] 72
Analysis of telomere maintenance related genes reveals NOP10 as a new metastatic-risk marker in pheochromocytoma/paraganglioma 72
Potential pitfalls of SDH immunohistochemical detection in paragangliomas and phaeochromocytomas harbouring germline SDHx gene mutation 72
Prognostic Value of Microscopic Tumor Necrosis in Adrenal Cortical Carcinoma 71
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question 70
The aggressiveness of succinate dehydrogenase subunit B-deficient chromaffin cells is reduced when their bioelectrical properties are restored by glibenclamide 69
Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment 69
Intratumour microbiota modulates adrenocortical cancer responsiveness to mitotane 67
New Findings on Presentation and Outcome of Patients With Adrenocortical Cancer: Results From a National Cohort Study 67
Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN) 64
[68Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation 63
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study 62
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study 58
Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paraganglioma 55
Pheochromocytomas and paragangliomas as causes of endocrine hypertension 54
Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma 51
Anatomical and functional changes of the fetal adrenal gland in intrauterine growth restriction 46
Targeted Next Generation Sequencing molecular profiling and its clinical application in adrenocortical cancer 45
Volumetric evaluation of CT images of adrenal glands in primary aldosteronism 44
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 40
The penetrance of MEN2 pheochromocytoma is not only determined byRETmutations 39
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma 32
Malignant Pheochromocytoma 30
High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study 19
Totale 7.110
Categoria #
all - tutte 22.352
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.352


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020394 0 0 0 0 0 0 0 106 111 81 75 21
2020/2021598 47 58 44 57 38 64 35 43 56 88 28 40
2021/2022396 10 28 26 34 21 24 10 59 17 24 32 111
2022/20231.000 95 238 41 59 48 149 148 39 106 18 22 37
2023/2024619 11 47 87 29 49 99 19 109 33 66 52 18
2024/20252.977 116 384 226 634 920 476 103 118 0 0 0 0
Totale 7.110